2D Structure
loading...
2D chemical structural formula diagram.
3D Structure
loading...
This 3D model represents a theoretically simulated conformation and is for reference only.
Check the
Catadegbrutinib (BGB-16673)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 3-tert-butyl-N-[(1R)-1-[4-[6-[6-[4-[[1-[4-(2,4-dioxo-1,3-diazinan-1-yl)phenyl]piperidin-4-yl]methyl]piperazin-1-yl]-3-pyridinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide | |
|---|---|---|
| CAS Number | 2736508-60-2 | |
| Molecular Formula |
C47H54N12O4 |
|
| Molecular Weight (MW) | 851.01 | |
| InChIKey | ZSOLMVZWDSGPDD-SSEXGKCCSA-N |
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(117.5 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
100 mg/mL
(117.5 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
100 mg/mL
(117.5 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Catadegbrutinib (BGB-16673) Mechanism of Action: BTK Inhibition in B Cells Research
- Catadegbrutinib (BGB-16673) Clinical Trials
- Catadegbrutinib (BGB-16673): Selectivity & Specificity
- Catadegbrutinib (BGB-16673) Working Concentration | Cell Culture | Treatment
- Catadegbrutinib (BGB-16673) Solubility in DMSO
- Catadegbrutinib (BGB-16673) Stock Solution
- Catadegbrutinib (BGB-16673) Storage
- Catadegbrutinib (BGB-16673) Stability
- Catadegbrutinib (BGB-16673) Combination Database
- Catadegbrutinib (BGB-16673) Molecular Weight
- Catadegbrutinib (BGB-16673) CAS Number
- Catadegbrutinib (BGB-16673) IC50 for Cell-based and Cell-free Assays
- Catadegbrutinib (BGB-16673) MedChemExpress (HY-160141)? Try a better option.
- Catadegbrutinib (BGB-16673) Sigma (AMBH9AD248A5)? Try a better option.
- Catadegbrutinib (BGB-16673) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.